These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8607668)

  • 1. Adenosine effectively controls pulmonary hypertension after cardiac operations.
    Fullerton DA; Jones SD; Grover FL; McIntyre RC
    Ann Thorac Surg; 1996 Apr; 61(4):1118-23; discussion 1123-4. PubMed ID: 8607668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine is a selective pulmonary vasodilator in cardiac surgical patients.
    Fullerton DA; Kirson LE; Jones SD; McIntyre RC
    Chest; 1996 Jan; 109(1):41-6. PubMed ID: 8549214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
    Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
    Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
    J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation.
    Fullerton DA; Jones SD; Jaggers J; Piedalue F; Grover FL; McIntyre RC
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):753-62; discussion 762-3. PubMed ID: 8614135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of adenosine as a pulmonary vasodilator during weaning from extracorporeal circulation after mitral valve replacement in a patient with severe pulmonary hypertension].
    Charco Mora P; Cantó Pastor M; García Escobar M
    Rev Esp Anestesiol Reanim; 1999 May; 46(5):223-5. PubMed ID: 10379190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.
    Tritapepe L; Voci P; Cogliati AA; Pasotti E; Papalia U; Menichetti A
    Crit Care Med; 1999 Oct; 27(10):2180-3. PubMed ID: 10548203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective control of refractory pulmonary hypertension after cardiac operations.
    Fullerton DA; Jaggers J; Piedalue F; Grover FL; McIntyre RC
    J Thorac Cardiovasc Surg; 1997 Feb; 113(2):363-8; discussion 368-70. PubMed ID: 9040631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study.
    Morelli A; Teboul JL; Maggiore SM; Vieillard-Baron A; Rocco M; Conti G; De Gaetano A; Picchini U; Orecchioni A; Carbone I; Tritapepe L; Pietropaoli P; Westphal M
    Crit Care Med; 2006 Sep; 34(9):2287-93. PubMed ID: 16791109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol.
    Rossi R; Coppi F; Sgura F; Monopoli D; Boriani G
    Pulm Pharmacol Ther; 2018 Apr; 49():147-151. PubMed ID: 28642014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation.
    Wagner F; Dandel M; Günther G; Loebe M; Schulze-Neick I; Laucke U; Kuhly R; Weng Y; Hetzer R
    Circulation; 1997 Nov; 96(9 Suppl):II-291-6. PubMed ID: 9386113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
    Patterson KW; Deb B; Kavanagh BP; Pearl RG
    Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgery.
    Beck JR; Mongero LB; Kroslowitz RM; Choudhri AF; Chen JM; DeRose JJ; Argenziano M; Smerling AJ; Oz MC
    Perfusion; 1999 Jan; 14(1):37-42. PubMed ID: 10074645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension.
    Argenziano M; Choudhri AF; Moazami N; Rose EA; Smith CR; Levin HR; Smerling AJ; Oz MC
    Ann Thorac Surg; 1998 Feb; 65(2):340-5. PubMed ID: 9485226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.
    Cailes J; Winter S; du Bois RM; Evans TW
    Chest; 1998 Jul; 114(1):178-84. PubMed ID: 9674467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Goal-Directed Hemodynamic Optimization Therapy Based on Major Vasopressor during Corrective Cardiac Surgery in Patients with Severe Pulmonary Arterial Hypertension: A Pilot Study.
    Li S; Ma Q; Yang Y; Lu J; Zhang Z; Jin M; Cheng W
    Heart Surg Forum; 2016 Dec; 19(6):E297-E302. PubMed ID: 28054902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.